66302-110 : Remodulin 200 mg/20ml Intravenous; Subcutaneous Injection, Solution


NDC: 66302-110
Labeler: United Therapeutics Corporation
Product Type: Human Prescription Drug
Drug Name:  Remodulin
Dosage Form: Intravenous; Subcutaneous Injection, Solution
Application #: NDA021272
Rev. Date: 


NDC Package Codes:

  • 66302-110-01: 1 VIAL IN 1 BOX (66302‑110‑01) > 20 ML IN 1 VIAL

Active Ingredients:

  • Treprostinil

Dosage Strength:

  • 200 mg/20mL

Pharmaceutical Classes:

  • Prostacycline Vasodilator [EPC]
  • Prostaglandins I [CS]
  • Vasodilation [PE]

Related Products:

Based on records with the same trade name.
  • 66302-101 Remodulin 20 mg/20ml Intravenous; Subcutaneous Injection, Solution by United Therapeutics Corporation
  • 66302-102 Remodulin 50 mg/20ml Intravenous; Subcutaneous Injection, Solution by United Therapeutics Corporation
  • 66302-105 Remodulin 100 mg/20ml Intravenous; Subcutaneous Injection, Solution by United Therapeutics Corporation
  • 66302-111 Remodulin 2 mg/20ml Intravenous; Subcutaneous Injection, Solution by United Therapeutics Corporation
  • 66302-112 Remodulin 4 mg/20ml Intravenous; Subcutaneous Injection, Solution by United Therapeutics Corporation
  • 66302-114 Remodulin 8 mg/20ml Intravenous; Subcutaneous Injection, Solution by United Therapeutics Corporation
  • 66302-120 Remodulin 400 mg/20ml Intravenous; Subcutaneous Injection, Solution by United Therapeutics Corporation

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 66302-110 QR Code

< Prev: 66302-105Next: 66302-111 >

Related Discussions:

Orenitram & Treprostinil Availability
Hello. I'm looking for Orenitram tablets and Treprostinil. Can you tell me about their availability please? It's...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.